The results of different studies [2,3,11], suggested a role for Melusin in cardiomyopathies as modifier gene, whose inactivation worsens the pathology and/or increases susceptibility to heart failure in response to different pathological conditions. This evidence concerns the gene ITGB1BP2 and heart failure.